Home Vertex Pharmaceuticals Incorporated (VRTX) Earns Outperform Rating from Leerink Swann
 

Keywords :   


Vertex Pharmaceuticals Incorporated (VRTX) Earns Outperform Rating from Leerink Swann

2016-04-10 19:10:39| Biotech - Topix.net

A number of other research firms also recently weighed in on VRTX. Piper Jaffray reaffirmed an overweight rating and set a $180.00 price target on shares of Vertex Pharmaceuticals in a research note on Tuesday, January 5th.

Tags: rating incorporated pharmaceuticals earns

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
13.06Musk says Tesla investors voting yes for pay deal
13.06Atlantic Tropical Weather Outlook
13.06Eastern North Pacific Tropical Weather Outlook
13.06US widens Russia sanctions in banking crackdown
13.06Atlantic Tropical Weather Outlook
13.06Eastern North Pacific Tropical Weather Outlook
13.06'We are creating new crops five-times faster'
12.06Atlantic Tropical Weather Outlook
More »